Berikutnya

Putar otomatis

Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL

9 Tampilan • 08/09/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis